ORG Wealth Partners LLC bought a new stake in Oscar Health, Inc. (NYSE:OSCR – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 7,434 shares of the company’s stock, valued at approximately $100,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of OSCR. Principal Financial Group Inc. raised its stake in Oscar Health by 40.8% in the second quarter. Principal Financial Group Inc. now owns 26,266 shares of the company’s stock valued at $416,000 after buying an additional 7,616 shares in the last quarter. Rhumbline Advisers raised its stake in Oscar Health by 8.7% in the second quarter. Rhumbline Advisers now owns 270,341 shares of the company’s stock valued at $4,277,000 after buying an additional 21,717 shares in the last quarter. Victory Capital Management Inc. raised its stake in Oscar Health by 114.1% in the second quarter. Victory Capital Management Inc. now owns 40,976 shares of the company’s stock valued at $648,000 after buying an additional 21,840 shares in the last quarter. Arizona State Retirement System raised its stake in Oscar Health by 3.7% in the second quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock valued at $602,000 after buying an additional 1,351 shares in the last quarter. Finally, Quest Partners LLC acquired a new stake in Oscar Health in the second quarter valued at $93,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of research firms have weighed in on OSCR. UBS Group began coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target on the stock. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and cut their price target for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Finally, Jefferies Financial Group assumed coverage on Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price on the stock. Two analysts have rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Oscar Health has an average rating of “Hold” and an average price target of $21.56.
Oscar Health Stock Performance
Shares of OSCR stock opened at $14.12 on Friday. The stock has a market capitalization of $3.49 billion, a PE ratio of -235.29 and a beta of 1.70. Oscar Health, Inc. has a 52-week low of $9.70 and a 52-week high of $23.79. The stock’s 50-day moving average price is $15.10 and its 200 day moving average price is $16.89. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.
Oscar Health (NYSE:OSCR – Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business’s revenue was up 68.3% on a year-over-year basis. During the same quarter last year, the firm earned ($0.29) EPS. As a group, equities research analysts forecast that Oscar Health, Inc. will post -0.01 EPS for the current year.
Insider Activity at Oscar Health
In other Oscar Health news, Director Thrive Partners Vii Growth Gp, acquired 420,819 shares of the stock in a transaction on Tuesday, November 12th. The shares were bought at an average price of $13.68 per share, with a total value of $5,756,803.92. Following the acquisition, the director now owns 5,452,081 shares of the company’s stock, valued at $74,584,468.08. This trade represents a 8.36 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Vice Chairman Joshua Kushner acquired 276,040 shares of the stock in a transaction on Monday, November 11th. The stock was acquired at an average cost of $13.58 per share, for a total transaction of $3,748,623.20. Following the acquisition, the insider now directly owns 5,031,262 shares in the company, valued at $68,324,537.96. This represents a 5.80 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. 25.11% of the stock is currently owned by insiders.
Oscar Health Company Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading
- Five stocks we like better than Oscar Health
- With Risk Tolerance, One Size Does Not Fit All
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How to Find Undervalued Stocks
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.